CardioVention CORx
This article was originally published in The Gray Sheet
Executive Summary
Minimally-invasive circulatory support system receives 510(k) clearance from FDA and is granted a European CE mark, firm announces April 30. The device can be used as either supplementary circulatory support during perfusion-assisted beating heart surgery or for stopped heart procedures. Clinical studies demonstrated the CORx to be associated with lower post-operative bleeding, shorter intubation time, decreased hemodilution and an increased platelet count compared with conventional heart-lung machines...